Live Breaking News & Updates on கேரி கேமிஞானி

Stay updated with breaking news from கேரி கேமிஞானி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Acacia Pharma Group plc Announcements | Acacia Pharma Group plc: Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US


™ (remimazolam injection)
US commercial rights to BYFAVO were in-licensed from Cosmo Pharmaceuticals NV (“Cosmo”) in January 2020 and it was approved in July 2020 for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less which make up around 40m procedures a year in the US, including 25m gastro-intestinal procedures
3 for an estimated >$1.5 billion annual total addressable market
4.
References
1. Calculations based on available procedural data, applied Compound Annual Growth Rate and quantitative market research responses as follows: National Hospital Discharge Survey, 2006; National Survey of Ambulatory Surgery, 2006 (as revised in 2009); Source Healthcare; NCHS 2005; Life Science Strategy Group, LLC Market Research; Apfel et al.,2004. ....

United Kingdom , United States , Talmage Egan , Irina Koffler , Frazer Hall , Mike Bolinder , Gary Gemignani , Richard Dutton , Deb Hussain , Chris Van Raemdonck , University Of Utah , International Media , Link Group For Cosmo Technologies , Department Of Anesthesiology , National Hospital Discharge , Acacia Pharma Group , Data Research , Quantitative Market Research , Baylor Scott White Health , Life Science Strategy Group , National Survey Of Ambulatory Surgery , Market Research , American Society Of Anesthesiologists , Cosmo Pharmaceuticals Nv , Paion United Kingdom , Significant Continued Progress ,

Investegate |Acacia Pharma Group plc Announcements | Acacia Pharma Group plc: Acacia Pharma Becomes New Industry Supporter of the American Society of Anesthesiologists


, 07:00 CEST
: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, is proud to be named a new Industry Supporter of the American Society of Anesthesiologists (“ASA” or the “Society”).
Launched in 2010, ASA’s Industry Supporter Program is limited to ten organizations. Participation is intended for companies who want to stand apart by showcasing high-level commitment to the education of physician anesthesiologists, the anesthesia care team and advancement of the specialty. ....

San Diego , United States , United Kingdom , Irina Koffler , Frazer Hall , Mike Bolinder , Gary Gemignani , Gabriel Fox , Citigate Dewe Rogerson , Chris Van Raemdonck , Beverlyk Philip , American Society , Industry Supporter Program , American Society Of Anesthesiologists , International Media , Acacia Pharma Group , Paion United Kingdom , Acacia Pharma Becomes New Industry Supporter , Pharma Becomes New Industry Supporter , Industry Supporter , Supporter Program , Acacia Pharma , Practice Management , Industry Supporters , Pharma Group , Paion United Kingdom Limited ,